More legal evolution in the compounding GLP-1 (tirzaperitide / Zepbound) saga

Mark Ziats
Jan 4, 2025
1 min read

Updated: Oct 25, 2025

FDA Announced Removal of Tirzepatide from the Drug Shortage List

Recent Posts

Early TAVR for asymptomatic aortic stenosis

There have been many ongoing trials on this topic and they are finally starting to conclude that intervening early, even when the patient is asymptomatic, is beneficial once echocardiogram shows the p

Vaginal Estrogen and Stroke Risk

We get a lot of questions from women who would benefit from vaginal/topical estrogen but are appropriately concerned about increased risk for heart attack and stroke with estrogen supplementation. A n

Insomnia in Primary Care

Comments